Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
11.31
-0.67 (-5.59%)
Mar 20, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $433 million as of March 20, 2026. Its market cap has increased by 16.64% in one year.
Market Cap
433.00M
Enterprise Value
188.23M
1-Year Change
16.64%
Ranking
Category
Stock Price
$11.31
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $251.01M to $433.00M, an increase of 72.50%. That is a compound annual growth rate of 13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 407.16M | 10.44% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | 251.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 445.63M |
| Shattuck Labs | 445.13M |
| Absci | 445.10M |
| Aclaris Therapeutics | 445.00M |
| 4D Molecular Therapeutics | 439.55M |
| Eupraxia Pharmaceuticals | 438.91M |
| Maravai LifeSciences Holdings | 436.22M |
| Century Therapeutics | 434.93M |